CRA Internl. Reports Rec Q3 Rev & Best-Ever Results
Charles River Associates reported record Q3 fiscal 2026 revenue driven by broad-based practice growth, and increased quarterly dividend while narrowing full-year margin guidance.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Charles River Associates reported record Q3 fiscal 2026 revenue driven by broad-based practice growth, and increased quarterly dividend while narrowing full-year margin guidance.
Axcelis Technologies reported a 11.3% rise in Q3 2026 revenue to $237.8 million, beating expectations with crowding metrics. The semiconductor equipment maker raised its 2026 outlo…
Company reported Q3 2026 revenue of $68 million. Investors should note the $125 million milestone from Sanofi and revised full-year revenue guidance.
InMed Pharmaceuticals Inc. has obtained shareholder approval for a corporate name change to Mentari Therapeutics, Inc., and completed a share consolidation 1:10 effective November …
Insight Enterprises reported strong 22% quarterly sales growth and raised FY26 outlook. Net income fell 57% due to one-time costs.
Acorn Energy, Inc. reported a 4.6% increase in Q3 total revenue to $2.6 million and strong operating cash flow of approximately $1 million. The company completed the Gen-Tracker ac…
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Archer Investment Corp.
Jerash Holdings Board approved a regular quarterly dividend of $0.05 per share payable on November 23, 2026. This payout is consistent with the company's financial policies and is …
BlackRock TCP Capital Corp reported a shift in Q3 2026 results and announced a forward dividend, following a recently completed strategic portfolio sale.
The company reported solid Q2 fiscal 2027 results and raised its revenue and operating margin outlook for the full fiscal year.
Lifetime Brands reported a 3.4% increase in net sales to $177.7 million and declared a regular quarterly dividend. Additionally, the board authorized a new $20 million share repurc…
BGC Group reported record third-quarter revenues of $833 million, up 13%, driven by growth in ECS, Rates, FX, and Equities. The strong results drove company earnings to all-time hi…
Shattuck Labs initiated a Phase 2 clinical trial for its lead DR3 antibody candidate SL-325 in hidradenitis suppurativa. This diversifies its clinical pipeline and positions the co…
Globalstar generated $70.9 million in Q3 2026 revenue and successfully launched the first set of HIBLEO-4 replacement satellites, while awaiting the completion of its merger transa…
Adagio Medical Holdings Inc. filed documents to effect a 30-for-1 reverse stock split effective as of Nov. 6, 2026. This structural change to the company's capitalization will be a…
Company filed a confidential investor presentation discussing an acquisition process, regulatory approvals, and market risks. Market relevance: Indicates active M&A activity as the…
NetScout reported mixed Q2 results with revenue down 1.4% to $222.2M due to product declines but service growth, while concurrently boosting shareholder returns via a $77M stock bu…
Radian reported a 106% revenue increase driven by split specialty and mortgage lines in Q3 2026, with net income rising to $172 million and share buybacks reaching $379 million yea…
Intensity Therapeutics resumed patient enrollment in two key oncology studies, INVINCIBLE-3 for soft tissue sarcoma and INVINCIBLE-4 for TNBC. The company reported $8.5 million in …
ACI Worldwide reported Q3 2026 revenue and bookings, raising adjusted EBITDA guidance while achieving a first ACI Connetic customer go-live and repurchasing $157 million in shares …